Rapid Alert
SPURIOUS DETECTED – Injection OXYZON 5% (Veterinary)
| DRAP Alert No | No I/S/10-25-87 |
| Action Date | 13th October, 2025 |
| Target Audience | 1. Regulatory Field Force of DRAP and Provincial Drug Control departments. 2. Healthcare Professionals 3. Pharmacies and medical stores |
| Problem Statement | Directorate of Drugs Control Punjab informed Drug Regulatory Authority of Pakistan that the sample of below mentioned Veterinary drug product has been declared as ‘Spurious’. |
The product identification details are as under: –
Therapeutic Good Affected:-
| S# | Product Name | Batch No. | Manufacturers | Remarks |
| 1. | Injection OXYZON 5% Each ml contains: Oxytetracycline Hcl ……. 50mg | AP/INJ-G/24-18 | M/s. Amazon Pharmaceutical (Pvt) Ltd. Plot No. 10/A & 29/B, Small Industrial Estate, Bhimber, AJK (DML # 000881) | The Sample is declared as “SPURIOUS” as per section 3(zb)(i) of the Drugs Act 1976. |
| Risk Statement | The circulation of such a product in the market poses a serious public health hazard, particularly in rural and peri-urban livestock-dependent populations, where injectable antibiotics are widely used without adequate medical supervision. The unverified origin and uncertain quality of this spurious drug may lead to therapeutic failure, antimicrobial resistance, and potential toxicity in animals, indirectly affecting the food chain and community health. This situation raises grave concerns regarding the integrity of manufacturing and distribution practices, warranting urgent and coordinated regulatory intervention to protect public and veterinary health. |
| Action Initiated | The Regulatory Field Force has been directed to conduct surveillance activities to confiscate the abovementioned Spurious product. All Pharmacists, chemists, and other healthcare professionals working at distributions, pharmacies, healthcare facilities, and other aspects of the supply chain system should immediately check the stock, and information related to the suppliers of such products should be provided to the Regulatory field force (DRAP, Provincial Drug Control Departments) to ensure the removal of these product from the circulation. |
| Advice for Healthcare Professionals | Healthcare professionals, veterinarians, and distributors are advised to immediately discontinue the use, prescription, or sale of Injection OXYZON 5% (Batch No. AP/INJ-G/24-18) manufactured by M/s Amazon Pharmaceutical (Pvt) Ltd., Bhimber (DML #000881), as the product has been declared “Spurious” and its safety, efficacy, and quality cannot be assured. They should verify stock authenticity through label and batch details before administration or dispensing, report any adverse reactions or therapeutic failures to DRAP’s Med Vigilance Cell or the concerned Provincial Quality Control Office, and ensure the use of only registered, traceable products obtained through authorized supply chains in compliance with the Drugs Act, 1976 and DRAP Act, 2012. |
| Advice for Consumers | Animal owners are advised not to use Injection OXYZON 5% (Batch No. AP/INJ-G/24-18) manufactured by M/s Amazon Pharmaceutical (Pvt) Ltd., Bhimber (DML #000881), as it has been declared “Spurious” and may pose serious health risks. They should stop using any remaining stock immediately and report the product to the nearest Drug Inspector, Provincial Health Department, or DRAP Field Office. Always purchase medicines and veterinary products only from licensed pharmacies or authorized distributors, ensure the product has a valid registration number, and avoid medicines of unknown or unverifiable origin to protect health and safety. |